---
title: "\"Performance\" EXTRAWELL PHAR reported a mid-term loss of 460 million yuan, turning from profit to loss"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/267972473.md"
description: "EXTRAWELL PHAR announced its interim results for the six months ending in September, with revenue of 28.01 million yuan, a year-on-year decrease of 9%. It recorded a loss of 460 million yuan, compared to a net profit of 101 million yuan in the same period last year, turning from profit to loss; the loss per share was 19.09 cents. No dividend was declared"
datetime: "2025-11-30T11:52:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267972473.md)
  - [en](https://longbridge.com/en/news/267972473.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267972473.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/267972473.md) | [English](https://longbridge.com/en/news/267972473.md)


# "Performance" EXTRAWELL PHAR reported a mid-term loss of 460 million yuan, turning from profit to loss

EXTRAWELL PHAR (00858.HK) announced its interim results for the six months ending in September, with revenue of HKD 28.01 million, a year-on-year decrease of 9%. It recorded a loss of HKD 460 million, compared to a net profit of HKD 101 million in the same period last year, turning from profit to loss; the loss per share was HKD 0.1909. No dividend was declared

### 相關股票

- [EXTRAWELL PHAR (00858.HK)](https://longbridge.com/zh-HK/quote/00858.HK.md)

## 相關資訊與研究

- [Weak Statutory Earnings May Not Tell The Whole Story For NEPI Rockcastle (JSE:NRP)](https://longbridge.com/zh-HK/news/280961111.md)
- [Uber increases stake in WeRide as robotaxi partnership ramps up in Dubai](https://longbridge.com/zh-HK/news/281219301.md)
- [ZAWYA-PRESSR: ITIDA and plug and play conclude Aswan bootcamp series as startups secure EGP 200mln in Upper Egypt](https://longbridge.com/zh-HK/news/281122065.md)
- [BUZZ-Gold miners gain as bullion prices tick higher](https://longbridge.com/zh-HK/news/281178839.md)
- [SSY Group Wins China Approval for Upadacitinib Bulk Drug](https://longbridge.com/zh-HK/news/281103720.md)